Review Registration - Organization

This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.

Registration ID: 762033
Submitted by lobbyist on: April 13, 2018 11:40:17 AM
Accepted by Registrar on: April 13, 2018 12:18:59 PM

Designated Filer Information

Gundersen, Stephen  
2100 Derry Road West  
Mississauga, ON, L5N 0B3
905-288-6000
Canada  

Organization Information

Becton Dickinson Canada Inc  
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and healthcare worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures and support the management of diabetes.
2100 Derry Road West  
Mississauga, ON, L5N 0B3
905-288-6000
Canada  

Relevant Affiliates


Type:

Business Name Mailing Address Contact Information
Becton, Dickinson and Company 1 Becton Drive
Franklin Lakes, NJ
07417
United States of America
Phone:

Government or Government Agency Funding


The organization does not receive any funding from a government or government agency.

Other Controlling or Directing Interests

The organization has no other controlling or directing interests.

Active Registration Period

April 13, 2018  
October 13, 2018  

Organization's In-House Lobbyists

 



Name: Ashton, Sarah Teresa
 
April 13, 2018  
Inactivation Date: November 8, 2018

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

Health

Development, establishment, amendment or termination of any program, policy or decision

British Columbia healthcare strategy with respect to patient safety, managing high-risk drugs, medication errors, healthcare worker safety, infection and disease prevention, antimicrobial resistance, and laboratory diagnostic testing. British Columbia science & technology strategy with respect to medical technology, specifically focusing on accelerating innovation to improve health and economic outcomes. British Columbia guidelines with respect to procurement of medical technologies and adoption of innovation in the healthcare industry. British Columbia science & technology strategy, focusing on promoting collaboration with respect to clinical and scientific research in the healthcare industry. British Columbia healthcare strategy with respect to diabetes, cancer testing and long-term care. British Columbia policies related to lab testing and code approvals for reimbursement.

Target Contacts

Target Type Name Title or Constituency Date Added
Public Agency BC Patient Safety and Quality Council April 13, 2018
Public Agency Health April 13, 2018
Public Agency Providence Health Care Society April 13, 2018
Public Agency Provincial Health Services Authority April 13, 2018

Health

Introduction, modification or repeal of legislation, a bill or regulation

British Columbia budget with respect to science and technology in the healthcare sector, specifically with respect to medical technology and devices. British Columbia budget with respect to public sector investments in long-term care and residential care.

Target Contacts

Target Type Name Title or Constituency Date Added
Public Agency BC Patient Safety and Quality Council April 13, 2018
Public Agency Health April 13, 2018
Public Agency Providence Health Care Society April 13, 2018
Public Agency Provincial Health Services Authority April 13, 2018

Name: Baginska, Eva
 
April 13, 2018  
Inactivation Date: November 8, 2018

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

Health

Development, establishment, amendment or termination of any program, policy or decision

British Columbia healthcare strategy with respect to patient safety, managing high-risk drugs, medication errors, healthcare worker safety, infection and disease prevention, antimicrobial resistance, and laboratory diagnostic testing. British Columbia science & technology strategy with respect to medical technology, specifically focusing on accelerating innovation to improve health and economic outcomes. British Columbia guidelines with respect to procurement of medical technologies and adoption of innovation in the healthcare industry. British Columbia science & technology strategy, focusing on promoting collaboration with respect to clinical and scientific research in the healthcare industry. British Columbia healthcare strategy with respect to diabetes, cancer testing and long-term care. British Columbia policies related to lab testing and code approvals for reimbursement.

Target Contacts

Target Type Name Title or Constituency Date Added
Public Agency BC Patient Safety and Quality Council April 13, 2018
Public Agency Health April 13, 2018
Public Agency Provincial Health Services Authority April 13, 2018

Health

Introduction, modification or repeal of legislation, a bill or regulation

British Columbia budget with respect to science and technology in the healthcare sector, specifically with respect to medical technology and devices. British Columbia budget with respect to public sector investments in long-term care and residential care.

Target Contacts

Target Type Name Title or Constituency Date Added
Public Agency BC Patient Safety and Quality Council April 13, 2018
Public Agency Health April 13, 2018
Public Agency Provincial Health Services Authority April 13, 2018

Name: Gundersen, Stephen
 
April 13, 2018  
Inactivation Date: November 8, 2018

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

Health

Development, establishment, amendment or termination of any program, policy or decision

British Columbia healthcare strategy with respect to patient safety, managing high-risk drugs, medication errors, healthcare worker safety, infection and disease prevention, antimicrobial resistance, and laboratory diagnostic testing. British Columbia science & technology strategy with respect to medical technology, specifically focusing on accelerating innovation to improve health and economic outcomes. British Columbia guidelines with respect to procurement of medical technologies and adoption of innovation in the healthcare industry. British Columbia science & technology strategy, focusing on promoting collaboration with respect to clinical and scientific research in the healthcare industry. British Columbia healthcare strategy with respect to diabetes, cancer testing and long-term care. British Columbia policies related to lab testing and code approvals for reimbursement.

Target Contacts

Target Type Name Title or Constituency Date Added
Public Agency BC Patient Safety and Quality Council April 13, 2018
Public Agency Health April 13, 2018
Public Agency Provincial Health Services Authority April 13, 2018

Health

Introduction, modification or repeal of legislation, a bill or regulation

British Columbia budget with respect to science and technology in the healthcare sector, specifically with respect to medical technology and devices. British Columbia budget with respect to public sector investments in long-term care and residential care.

Target Contacts

Target Type Name Title or Constituency Date Added
Public Agency BC Patient Safety and Quality Council April 13, 2018
Public Agency Health April 13, 2018
Public Agency Provincial Health Services Authority April 13, 2018

Name: Kelly, Sean
 
April 13, 2018  
Inactivation Date: October 11, 2018

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

Health

Development, establishment, amendment or termination of any program, policy or decision

British Columbia healthcare strategy with respect to patient safety, managing high-risk drugs, medication errors, healthcare worker safety, infection and disease prevention, antimicrobial resistance, and laboratory diagnostic testing. British Columbia science & technology strategy with respect to medical technology, specifically focusing on accelerating innovation to improve health and economic outcomes. British Columbia guidelines with respect to procurement of medical technologies and adoption of innovation in the healthcare industry. British Columbia science & technology strategy, focusing on promoting collaboration with respect to clinical and scientific research in the healthcare industry. British Columbia healthcare strategy with respect to diabetes, cancer testing and long-term care. British Columbia policies related to lab testing and code approvals for reimbursement.

Target Contacts

Target Type Name Title or Constituency Date Added
Public Agency BC Patient Safety and Quality Council April 13, 2018
Public Agency Health April 13, 2018
Public Agency Provincial Health Services Authority April 13, 2018

Health

Introduction, modification or repeal of legislation, a bill or regulation

British Columbia budget with respect to science and technology in the healthcare sector, specifically with respect to medical technology and devices. British Columbia budget with respect to public sector investments in long-term care and residential care.

Target Contacts

Target Type Name Title or Constituency Date Added
Public Agency BC Patient Safety and Quality Council April 13, 2018
Public Agency Health April 13, 2018
Public Agency Provincial Health Services Authority April 13, 2018

Name: Pasrija, Anuj
 
April 13, 2018  
Inactivation Date: November 8, 2018

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

Health

Development, establishment, amendment or termination of any program, policy or decision

British Columbia healthcare strategy with respect to patient safety, managing high-risk drugs, medication errors, healthcare worker safety, infection and disease prevention, antimicrobial resistance, and laboratory diagnostic testing. British Columbia science & technology strategy with respect to medical technology, specifically focusing on accelerating innovation to improve health and economic outcomes. British Columbia guidelines with respect to procurement of medical technologies and adoption of innovation in the healthcare industry. British Columbia science & technology strategy, focusing on promoting collaboration with respect to clinical and scientific research in the healthcare industry. British Columbia healthcare strategy with respect to diabetes, cancer testing and long-term care. British Columbia policies related to lab testing and code approvals for reimbursement.

Target Contacts

Target Type Name Title or Constituency Date Added
Public Agency BC Patient Safety and Quality Council April 13, 2018
Public Agency Health April 13, 2018
Public Agency Provincial Health Services Authority April 13, 2018

Health

Introduction, modification or repeal of legislation, a bill or regulation

British Columbia budget with respect to science and technology in the healthcare sector, specifically with respect to medical technology and devices. British Columbia budget with respect to public sector investments in long-term care and residential care.

Target Contacts

Target Type Name Title or Constituency Date Added
Public Agency BC Patient Safety and Quality Council April 13, 2018
Public Agency Health April 13, 2018
Public Agency Provincial Health Services Authority April 13, 2018

Name: Smallwood, Chelsea
 
April 13, 2018  
Inactivation Date: November 8, 2018

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

Health

Development, establishment, amendment or termination of any program, policy or decision

British Columbia healthcare strategy with respect to patient safety, managing high-risk drugs, medication errors, healthcare worker safety, infection and disease prevention, antimicrobial resistance, and laboratory diagnostic testing. British Columbia science & technology strategy with respect to medical technology, specifically focusing on accelerating innovation to improve health and economic outcomes. British Columbia guidelines with respect to procurement of medical technologies and adoption of innovation in the healthcare industry. British Columbia science & technology strategy, focusing on promoting collaboration with respect to clinical and scientific research in the healthcare industry. British Columbia healthcare strategy with respect to diabetes, cancer testing and long-term care. British Columbia policies related to lab testing and code approvals for reimbursement.

Target Contacts

Target Type Name Title or Constituency Date Added
Public Agency BC Patient Safety and Quality Council April 13, 2018
Public Agency Health April 13, 2018
Public Agency Provincial Health Services Authority April 13, 2018

Health

Introduction, modification or repeal of legislation, a bill or regulation

British Columbia budget with respect to science and technology in the healthcare sector, specifically with respect to medical technology and devices. British Columbia budget with respect to public sector investments in long-term care and residential care.

Target Contacts

Target Type Name Title or Constituency Date Added
Public Agency BC Patient Safety and Quality Council April 13, 2018
Public Agency Health April 13, 2018
Public Agency Provincial Health Services Authority April 13, 2018